CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity
about
Potential and real 'antineoplastic' and metabolic effect of metformin in diabetic and nondiabetic postmenopausal females.Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management.Severe Obesity Impacts Recurrence-Free Survival of Women with High-Risk Endometrial Cancer: Results of a French Multicenter Study.Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTEN.
P2860
CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity
@ast
CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity
@en
type
label
CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity
@ast
CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity
@en
prefLabel
CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity
@ast
CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity
@en
P2093
P2860
P921
P1433
P1476
CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity
@en
P2093
Adrienne McCampbell
David S Loose
Diana L Urbauer
Gregory L Shipley
Joseph Celestino
Karen H Lu
Melinda S Yates
Qian Zhang
Rosemarie Schmandt
Russell R Broaddus
P2860
P356
10.1016/J.YGYNO.2013.12.006
P407
P577
2014-04-01T00:00:00Z